{"id":4005,"date":"2017-08-12T17:27:51","date_gmt":"2017-08-12T17:27:51","guid":{"rendered":"https:\/\/andromedichyperthermia.com\/dr-salvattore-conte-ceo-ciro-zaccagnini-oncologic-hyperthermia-andromedic-hydeep-600-wm\/"},"modified":"2026-02-18T19:12:06","modified_gmt":"2026-02-18T19:12:06","slug":"onkologische-hyperthermie","status":"publish","type":"page","link":"https:\/\/andromedichyperthermia.com\/de\/onkologische-hyperthermie\/","title":{"rendered":"Arzt Salvatore Conte &#038; CEO Ciro Zaccagnini &#8211; onkologische Hyperthermie &#8211; medicina365.it"},"content":{"rendered":"<p><script type=\"application\/ld+json\">\n{\n  \"@context\": \"https:\/\/schema.org\",\n  \"@graph\": [\n    {\n      \"@type\": \"VideoObject\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/de\/onkologische-hyperthermie\/#video\",\n      \"name\": \"Onkologische Hyperthermie: Interview mit Dr. Salvatore Conte & CEO Ciro Zaccagnini\",\n      \"description\": \"Andromedic-CEO Ciro Zaccagnini und Dr. Salvatore Conte diskutieren \u00fcber die Innovationen von HY-DEEP 600WM und die Rolle der modulierten RF-Hyperthermie in der modernen Onkologie.\",\n      \"thumbnailUrl\": \"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/07\/advanced-modulated-RF-hyperthermia-device-Andromedic-HY-DEEP-600WM-local-oncologic-hyperthermia.jpg\",\n      \"uploadDate\": \"2024-07-17\",\n      \"contentUrl\": \"https:\/\/www.youtube.com\/watch?v=5teShJTVVf8\",\n      \"embedUrl\": \"https:\/\/www.youtube.com\/embed\/5teShJTVVf8\",\n      \"interactionStatistic\": {\n        \"@type\": \"InteractionCounter\",\n        \"interactionType\": { \"@type\": \"WatchAction\" },\n        \"userInteractionCount\": 400\n      }\n    },\n    {\n      \"@type\": \"MedicalWebPage\",\n      \"@id\": \"https:\/\/andromedichyperthermia.com\/de\/onkologische-hyperthermie\/#webpage\",\n      \"url\": \"https:\/\/andromedichyperthermia.com\/de\/onkologische-hyperthermie\/\",\n      \"name\": \"Fortschrittliche onkologische Hyperthermie - Andromedic Excellence\",\n      \"isPartOf\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/de\/#website\" },\n      \"inLanguage\": \"de-DE\",\n      \"mainEntity\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#hydeep-600wm\" },\n      \"author\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/de\/cristian-gologan\/#person\" },\n      \"mentions\": [\n        {\n          \"@type\": \"Person\",\n          \"name\": \"Dr. Salvatore Conte\",\n          \"jobTitle\": \"Medizinisch-Wissenschaftlicher Leiter\",\n          \"affiliation\": { \"@id\": \"https:\/\/andromedichyperthermia.com\/#organization\" }\n        },\n        {\n          \"@type\": \"Person\",\n          \"name\": \"Ciro Zaccagnini\",\n          \"jobTitle\": \"CEO von Andromedic Srl\"\n        }\n      ]\n    }\n  ]\n}\n<\/script><\/p>\n<div style=\"text-align: center; margin-bottom: 40px; padding: 20px;\">\n<h1 style=\"color: #1a2a6c; font-size: 36px; font-weight: 800; border-bottom: 4px solid #b21f1f; display: inline-block; padding-bottom: 10px;\">Wissenschaftliche F\u00fchrung &amp; Innovation<\/h1>\n<p style=\"font-size: 20px; color: #666; margin-top: 15px;\">Dr. Salvatore Conte &amp; CEO Ciro Zaccagnini \u00fcber die Zukunft der mHT<\/p>\n<\/div>\n<div style=\"max-width: 900px; margin: 0 auto 50px; line-height: 1.8; font-size: 18px; color: #2c3e50;\">In diesem exklusiven Interview diskutieren <a style=\"color: #b21f1f; font-weight: bold; text-decoration: none;\" href=\"https:\/\/andromedichyperthermia.com\/de\/hyperthermiearzt-salvatore-conte\/\">Dr. Salvatore Conte<\/a> (Medizinisch-Wissenschaftlicher Leiter) und <a style=\"color: #1a2a6c; font-weight: bold; text-decoration: none;\" href=\"\/de\/ciro-zaccagnini\/\">Ciro Zaccagnini<\/a> (CEO von Andromed Srl), warum die modulierte RF-Hyperthermie zu einer europ\u00e4ischen Exzellenz in der integrativen Onkologie avanciert. Sie erl\u00e4utern, wie das <strong>HY-DEEP 600WM System f\u00fcr fortschrittliche onkologische Hyperthermie<\/strong> modernste modulierte 13,56 MHz-Technologie nutzt, um Tumore pr\u00e4zise zu targetieren, w\u00e4hrend gesundes Gewebe ohne Nebenwirkungen geschont wird.<\/div>\n<div style=\"max-width: 1000px; margin: 0 auto 50px; border: 8px solid #f0f4f8; border-radius: 20px; overflow: hidden; box-shadow: 0 20px 40px rgba(0,0,0,0.1);\">\n<div style=\"position: relative; padding-bottom: 56.25%; height: 0;\"><iframe style=\"position: absolute; top: 0; left: 0; width: 100%; height: 100%; border: 0;\" src=\"https:\/\/www.youtube.com\/embed\/5teShJTVVf8\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/div>\n<\/div>\n<div style=\"display: grid; grid-template-columns: repeat(auto-fit, minmax(300px, 1fr)); gap: 30px; margin-bottom: 60px;\">\n<div style=\"background: #ffffff; padding: 30px; border-radius: 15px; border-top: 6px solid #1a2a6c; box-shadow: 0 4px 15px rgba(0,0,0,0.05);\">\n<h3 style=\"color: #1a2a6c; margin-bottom: 15px;\">Die 4. S\u00e4ule<\/h3>\n<p style=\"font-size: 16px;\">Hyperthermie ist offiziell als der vierte Grundpfeiler der Krebstherapie anerkannt, neben Chirurgie, Strahlentherapie und Chemotherapie.<\/p>\n<\/div>\n<div style=\"background: #ffffff; padding: 30px; border-radius: 15px; border-top: 6px solid #b21f1f; box-shadow: 0 4px 15px rgba(0,0,0,0.05);\">\n<h3 style=\"color: #b21f1f; margin-bottom: 15px;\">Synergetische Kraft<\/h3>\n<p style=\"font-size: 16px;\">Durch die Erh\u00f6hung der Tumoroxygenierung verbessert die modulierte RF-Hyperthermie (mHT) die Wirksamkeit von <a href=\"https:\/\/www.sciencedirect.com\/\" target=\"_blank\" rel=\"noopener\">Chemotherapie<\/a> und <a href=\"https:\/\/www.frontiersin.org\/\" target=\"_blank\" rel=\"noopener\">Immuntherapie<\/a> signifikant.<\/p>\n<\/div>\n<\/div>\n<div style=\"background: #f8faff; padding: 40px; border-radius: 20px; display: flex; flex-wrap: wrap; align-items: center; gap: 40px;\">\n<div style=\"flex: 1; min-width: 300px;\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone\" style=\"width: 100%; border-radius: 10px; box-shadow: 0 10px 20px rgba(0,0,0,0.1);\" src=\"https:\/\/andromedichyperthermia.com\/wp-content\/uploads\/2025\/07\/advanced-modulated-RF-hyperthermia-device-Andromedic-HY-DEEP-600WM-local-oncologic-hyperthermia.jpg\" alt=\"HY-DEEP 600WM onkologische Hyperthermie Ger\u00e4t\" width=\"674\" height=\"935\" title=\"\"><\/div>\n<div style=\"flex: 1.5; min-width: 300px;\">\n<h2 style=\"color: #1a2a6c; margin-bottom: 20px;\">HY-DEEP 600WM \u2013 Hochmodernes System f\u00fcr onkologische Hyperthermie<\/h2>\n<p style=\"font-size: 17px; margin-bottom: 25px;\">Ein medizinisches Ger\u00e4t der neuesten Generation f\u00fcr die lokale onkologische Tiefenhyperthermie, das Patienten weltweit eine nicht-invasive und komfortable Behandlungserfahrung bietet.<\/p>\n<p><a style=\"display: inline-block; background: #b21f1f; color: #fff; padding: 15px 35px; border-radius: 5px; text-decoration: none; font-weight: bold; text-transform: uppercase;\" href=\"https:\/\/andromedichyperthermia.com\/de\/tiefes-lokales-hyperthermiegeraet\/\">Technische Details explorieren<\/a><\/p>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Wissenschaftliche F\u00fchrung &amp; Innovation Dr. Salvatore Conte &amp; CEO Ciro Zaccagnini \u00fcber die Zukunft der mHT In diesem exklusiven Interview diskutieren Dr. Salvatore Conte (Medizinisch-Wissenschaftlicher Leiter) und Ciro Zaccagnini (CEO von Andromed Srl), warum die modulierte RF-Hyperthermie zu einer europ\u00e4ischen Exzellenz in der integrativen Onkologie avanciert. Sie erl\u00e4utern, wie das HY-DEEP 600WM System f\u00fcr fortschrittliche&hellip;<\/p>\n","protected":false},"author":1,"featured_media":17376,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-4005","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/pages\/4005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/comments?post=4005"}],"version-history":[{"count":0,"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/pages\/4005\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/media\/17376"}],"wp:attachment":[{"href":"https:\/\/andromedichyperthermia.com\/de\/wp-json\/wp\/v2\/media?parent=4005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}